Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence
- PMID: 21665147
- PMCID: PMC4890723
- DOI: 10.1016/j.ccr.2011.05.011
Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence
Abstract
Pancreatic acinar cells of adult mice (≥P60) are resistant to transformation by some of the most robust oncogenic insults including expression of K-Ras oncogenes and loss of p16Ink4a/p19Arf or Trp53 tumor suppressors. Yet, these acinar cells yield pancreatic intraepithelial neoplasias (mPanIN) and ductal adenocarcinomas (mPDAC) if exposed to limited bouts of non-acute pancreatitis, providing they harbor K-Ras oncogenes. Pancreatitis contributes to tumor progression by abrogating the senescence barrier characteristic of low-grade mPanINs. Attenuation of pancreatitis-induced inflammation also accelerates tissue repair and thwarts mPanIN expansion. Patients with chronic pancreatitis display senescent PanINs, providing they have received antiinflammatory drugs. These results support the concept that antiinflammatory treatment of people diagnosed with pancreatitis may reduce their risk of developing PDAC.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4890723/bin/emss-52291-f001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4890723/bin/emss-52291-f002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4890723/bin/emss-52291-f003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4890723/bin/emss-52291-f004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4890723/bin/emss-52291-f005.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4890723/bin/emss-52291-f006.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4890723/bin/emss-52291-f007.gif)
![Figure 8](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4890723/bin/emss-52291-f008.gif)
Similar articles
-
Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.Am J Pathol. 2016 Nov;186(11):2934-2944. doi: 10.1016/j.ajpath.2016.07.025. Epub 2016 Sep 14. Am J Pathol. 2016. PMID: 27639167
-
The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma.J Pathol. 2009 Oct;219(2):205-13. doi: 10.1002/path.2585. J Pathol. 2009. PMID: 19585519
-
Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18913-8. doi: 10.1073/pnas.0810097105. Epub 2008 Nov 21. Proc Natl Acad Sci U S A. 2008. PMID: 19028870 Free PMC article.
-
Chronic pancreatitis: a path to pancreatic cancer.Cancer Lett. 2014 Apr 10;345(2):203-9. doi: 10.1016/j.canlet.2013.08.015. Epub 2013 Aug 24. Cancer Lett. 2014. PMID: 23981573 Review.
-
Pancreatitis initiated pancreatic ductal adenocarcinoma: Pathophysiology explaining clinical evidence.Pharmacol Res. 2021 Jun;168:105595. doi: 10.1016/j.phrs.2021.105595. Epub 2021 Apr 3. Pharmacol Res. 2021. PMID: 33823219 Review.
Cited by
-
A Humanized Patient-Derived Xenograft Model for Pancreatic Cancer.Methods Mol Biol. 2024;2806:91-100. doi: 10.1007/978-1-0716-3858-3_8. Methods Mol Biol. 2024. PMID: 38676798
-
Macrophage-induced reactive oxygen species in the initiation of pancreatic cancer: a mini-review.Front Immunol. 2024 Mar 21;15:1278807. doi: 10.3389/fimmu.2024.1278807. eCollection 2024. Front Immunol. 2024. PMID: 38576613 Free PMC article. Review.
-
A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia.EMBO Rep. 2024 Apr;25(4):1886-1908. doi: 10.1038/s44319-024-00104-x. Epub 2024 Feb 27. EMBO Rep. 2024. PMID: 38413734 Free PMC article.
-
Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target.Front Immunol. 2024 Feb 1;15:1287459. doi: 10.3389/fimmu.2024.1287459. eCollection 2024. Front Immunol. 2024. PMID: 38361931 Free PMC article. Review.
-
Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammation.Cancer Lett. 2024 Apr 1;586:216694. doi: 10.1016/j.canlet.2024.216694. Epub 2024 Feb 1. Cancer Lett. 2024. PMID: 38307409
References
-
- Bonifazi M, Gallus S, Bosetti C, Polesel J, Serraino D, Talamini R, Negri E, La Vecchia C. Aspirin use and pancreatic cancer risk. Eur J Cancer Prev. 2010;19:352–354. - PubMed
-
- Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguría A, Zaballos A, Flores JM, Barbacid M, Beach D, et al. Tumour biology: senescence inpremalignant tumours. Nature. 2005;436:642. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous